Recent Investment Analysts’ Ratings Changes for Intuitive Surgical (ISRG)

A number of research firms have changed their ratings and price targets for Intuitive Surgical (NASDAQ: ISRG):

• 6/2/2026 – Intuitive Surgical had its “overweight” rating reaffirmed by Piper Sandler. They now have a $580.00 price target on the stock.
• 6/2/2026 – Intuitive Surgical had its price target lowered by Deutsche Bank Aktiengesellschaft from $440.00 to $366.00. They now have a “sell” rating on the stock.
• 5/27/2026 – Intuitive Surgical was given a new $558.00 price target by The Goldman Sachs Group, Inc..
• 5/24/2026 – Intuitive Surgical was downgraded by Wall Street Zen from “buy” to “hold”.
• 5/19/2026 – Intuitive Surgical had its “hold (c)” rating reaffirmed by Weiss Ratings.
• 5/18/2026 – Intuitive Surgical had its price target lowered by Bank of America Corporation from $650.00 to $520.00. They now have a “buy” rating on the stock.
• 5/16/2026 – Intuitive Surgical was upgraded by Wall Street Zen from “hold” to “buy”.
• 4/23/2026 – Intuitive Surgical was given a new $651.00 price target by Barclays PLC. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by HSBC Holdings plc from $653.00 to $604.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target raised by Robert W. Baird from $575.00 to $610.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target raised by The Goldman Sachs Group, Inc. from $609.00 to $621.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Jefferies Financial Group Inc. from $560.00 to $515.00. They now have a “hold” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Raymond James Financial, Inc. from $615.00 to $577.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Leerink Partners from $622.00 to $573.00. They now have an “outperform” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by JPMorgan Chase & Co. from $625.00 to $550.00. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by TD Cowen from $660.00 to $585.00. They now have a “buy” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its price target lowered by Piper Sandler from $620.00 to $580.00. They now have an “overweight” rating on the stock.
• 4/22/2026 – Intuitive Surgical had its “buy” rating reaffirmed by BTIG Research. They now have a $574.00 price target on the stock.
• 4/15/2026 – Intuitive Surgical had its price target lowered by Truist Financial Corporation from $650.00 to $580.00. They now have a “buy” rating on the stock.
• 4/15/2026 – Intuitive Surgical had its price target lowered by Robert W. Baird from $645.00 to $575.00. They now have an “outperform” rating on the stock.
• 4/13/2026 – Intuitive Surgical was given a new $525.00 price target by Mizuho. They now have a “neutral” rating on the stock.

Insider Buying and Selling

In related news, SVP Iman Jeddi sold 5,625 shares of the business’s stock in a transaction that occurred on Monday, June 1st. The shares were sold at an average price of $420.55, for a total value of $2,365,593.75. Following the completion of the transaction, the senior vice president owned 6,463 shares of the company’s stock, valued at $2,718,014.65. The trade was a 46.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Amy L. Ladd sold 500 shares of the company’s stock in a transaction on Tuesday, April 28th. The stock was sold at an average price of $473.46, for a total value of $236,730.00. Following the transaction, the director directly owned 239 shares in the company, valued at approximately $113,156.94. The trade was a 67.66% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 7,144 shares of company stock valued at $3,048,782 over the last 90 days. Corporate insiders own 0.60% of the company’s stock.

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.